Changes To OMB Indirect-Costs Guidelines May Not Satisfy Budget-Cutting Lawmakers

University groups work with Clinton administration to rewrite indirect-costs rules but will the new Congress ask for more ? Poorly understood, much maligned, and yet central to the work of research, indirect costs are due for a partial, but welcome, revamping under changes expected to be published this week by the Office of Management and Budget (OMB), according to university administrators and association officials. Indirect costs represent that part of a federal research grant that reimbu

Written byFranklin Hoke
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Poorly understood, much maligned, and yet central to the work of research, indirect costs are due for a partial, but welcome, revamping under changes expected to be published this week by the Office of Management and Budget (OMB), according to university administrators and association officials. Indirect costs represent that part of a federal research grant that reimburses the sponsoring institution for its contribution to a project, through support facilities and administrative overhead.

To calculate rates for indirect costs--that portion of a federal research grant used to pay for facilities and administrative costs--university accountants sit down with their ledgers and representatives from one government agency, their so-called cognizant agency, to negotiate. Together, they arrive at a rate, unique to each school, that is then honored by all other federal agencies awarding grants to that university. Most institutions negotiate with the Department of Health and Human Services (HHS), but a number of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo